These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 27751330)

  • 1. Hemolysis induced by PMIVSD occluder.
    Rao DS; Barik R; Siva Prasad A
    Indian Heart J; 2016 Sep; 68 Suppl 2(Suppl 2):S60-S63. PubMed ID: 27751330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcatheter closure of post-myocardial infarction ventricular defect: Where are we?
    Barik R
    Indian Heart J; 2016; 68(1):99-101. PubMed ID: 26896275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe Mechanical Hemolysis After Transcatheter Closure of a Traumatic Ventricular Septal Defect Using the Amplatzer Atrial Septal Occluder.
    Tang L; Tang JJ; Fang ZF; Hu XQ; Shen XQ; Zhou SH
    Int Heart J; 2016 Jul; 57(4):519-21. PubMed ID: 27357435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential management of post-myocardial infarction ventricular septal defects.
    Trivedi KR; Aldebert P; Riberi A; Mancini J; Levy G; Macia JC; Quilicci J; Habib G; Fraisse A
    Arch Cardiovasc Dis; 2015 May; 108(5):321-30. PubMed ID: 25754906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does the placement of an Amplatzer septal occluder device confer benefit in patients with a post-infarction ventricular septal defect?
    Dawson AG; Williams SG; Cole D
    Interact Cardiovasc Thorac Surg; 2014 Dec; 19(6):1040-7. PubMed ID: 25193971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Not Your Typical Hole-in-the-Wall: Percutaneous Closure of an Acquired Post-Myocardial Infarction Ventriculoatrial Gerbode Defect.
    Cheng R; Arsanjani R; Tat E; Cox J; Uberoi A; Aron R; Kar S
    JACC Cardiovasc Interv; 2015 Dec; 8(14):1905-6. PubMed ID: 26604054
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of Incomplete Closure of a Gerbode Defect With the Nit-Occlud Lê VSD Coil: Severe Hemolysis Requiring a Second Procedure.
    Pérez de Prado A; Zunzunegui Martínez JL; Carbonell de Blas R; Rodríguez García MÁ; Benito González T; Fernández Vázquez F
    Rev Esp Cardiol (Engl Ed); 2017 Oct; 70(10):872-873. PubMed ID: 28111108
    [No Abstract]   [Full Text] [Related]  

  • 8. Aortic regurgitation after closure of ventricular septal defect by transcatheter device: the long-term complication.
    Han Y; Li H; Zhu H; Sun G; Yin Q; Gu C
    Cardiol Young; 2020 Apr; 30(4):577-579. PubMed ID: 32102719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of severe hemolysis following Nit-Occlud Lê VSD coil implantation with Amplatzer Duct Occluder II.
    Bulut MO; Küçük M; Ballı Ş; Çelebi A
    Turk Kardiyol Dern Ars; 2016 Oct; 44(7):593-596. PubMed ID: 27774969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous closure of postinfarction ventricular septal defect: cardiac magnetic resonance-guided case selection and postprocedure evaluation.
    Artis NJ; Thomson J; Plein S; Greenwood JP
    Can J Cardiol; 2011; 27(6):869.e3-5. PubMed ID: 21652169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous Resolution of Residual Shunting in 2 Compromised Patients after Amplatzer Occlusion of Postinfarction Ventricular Septal Defects.
    Yanagiuchi T; Tada N; Suchi T; Mizutani Y; Matsumoto T; Sakurai M; Ootomo T
    Tex Heart Inst J; 2019 Feb; 46(1):44-47. PubMed ID: 30833838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcatheter closure of postmyocardial infarction, iatrogenic, and postoperative ventricular septal defects: The Mayo Clinic experience.
    Egbe AC; Poterucha JT; Rihal CS; Taggart NW; Cetta F; Cabalka AK; Pollak PM; Reeder GS; Hagler DJ
    Catheter Cardiovasc Interv; 2015 Dec; 86(7):1264-70. PubMed ID: 26033272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Techniques, Timing, and Prognosis of Transcatheter Post Myocardial Infarction Ventricular Septal Defect Repair.
    Faccini A; Butera G
    Curr Cardiol Rep; 2019 May; 21(7):59. PubMed ID: 31111245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longer-term outcome of perventricular device closure of muscular ventricular septal defects in children.
    Kang SL; Tometzki A; Caputo M; Morgan G; Parry A; Martin R
    Catheter Cardiovasc Interv; 2015 May; 85(6):998-1005. PubMed ID: 25573696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcatheter device closure of postmyocardial infarction ventricular septal defect.
    Nie YL; Lin MC; Lin WW; Wang CC; Chen CP; Lin CH; Shyu TC; Quek YW; Jan SL; Fu YC
    J Chin Med Assoc; 2017 Jan; 80(1):34-38. PubMed ID: 27889458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous Closure of a Large Postinfarct Ventricular Septal Defect With an Atrial Septal Defect Closure Device in a High Surgical Risk Patient.
    Long A; Talreja A; Baran D; Talreja D
    J Invasive Cardiol; 2021 Jun; 33(6):E485-E486. PubMed ID: 34089311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Closure of perimembranous ventricular septal defects with aneurysmal tissue using the Amplazter Duct Occluder I: lessons learned and medium term follow up.
    El Said HG; Bratincsak A; Gordon BM; Moore JW
    Catheter Cardiovasc Interv; 2012 Nov; 80(6):895-903. PubMed ID: 22907908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete atrioventricular block after percutaneous device closure of perimembranous ventricular septal defect: A single-center experience on 1046 cases.
    Bai Y; Xu XD; Li CY; Zhu JQ; Wu H; Chen SP; Chen F; You XH; Zhao XX; Qin YW
    Heart Rhythm; 2015 Oct; 12(10):2132-40. PubMed ID: 25981147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Risk Factors for Arrhythmia Post Transcatheter Closure of Perimembranous Ventricular Septal Defect.
    Li Y; Hua Y; Fang J; Wan C; Wang C; Zhou K
    J Invasive Cardiol; 2015 Aug; 27(8):E158-66. PubMed ID: 26232018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Gore Cardioform Atrial Septal Defect Occluder: A novel solution to the management of severe hemolysis following transcatheter septal defect closure.
    Naimi I; Jones TK; Steinberg Z
    Catheter Cardiovasc Interv; 2022 Apr; 99(5):1679-1682. PubMed ID: 35253339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.